SC13GNOV10

Company

Cellectar Biosciences, Inc.

Filed

December 10, 2010

Accession Number

0000905718-10-000210

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →